UAE at a glance
- Population
- 11.5 million 2025
- Life expectancy at birth
- 83.1 years, 2024
- People aged 65 and over
- 1.8 % of people, 2025
- Health spending per person
- 2,402 US$ per person, 2023
- Doctors
- 2.99 per 1,000 people, 2023
Updated
Reviewed by Vidhi Upadhyay
UAE Prostate Cancer Therapeutics Market Industry Trends and Forecast to 2034: Segmented by (Drug Class, Stage, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$90.8 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $71.1 Mn | — | — |
| 2025 (base) | $77.5 Mn | +$6.4 Mn | — |
| 2026 (forecast) | $84.4 Mn | +$7.0 Mn | +9% |
| 2027 (forecast) | $92.0 Mn | +$7.6 Mn | +18.8% |
| 2028 (forecast) | $100.3 Mn | +$8.3 Mn | +29.5% |
| 2029 (forecast) | $109.3 Mn | +$9.0 Mn | +41.2% |
| 2030 (forecast) | $119.2 Mn | +$9.8 Mn | +53.9% |
| 2031 (forecast) | $129.9 Mn | +$10.7 Mn | +67.7% |
| 2032 (forecast) | $141.6 Mn | +$11.7 Mn | +82.8% |
| 2033 (forecast) | $154.4 Mn | +$12.7 Mn | +99.3% |
| 2034 (forecast) | $168.2 Mn | +$13.9 Mn | +117.2% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $77.5 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $168.2 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 9.0% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Drug class, stage and end user (see all) |
| Key players | Johnson & Johnson, Pfizer Inc., Astellas Pharma Inc., Bayer AG, Novartis AG (see all) |
| Regulator in the UAE | EDESource: Emirates Drug Establishment. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Prostate cancer therapeutics include hormone therapies, androgen receptor inhibitors, PARP inhibitors and radioligand therapy.
Key segments of the prostate Cancer Therapeutics market include drug class (Androgen Receptor Inhibitors, GnRH Therapy and Radioligand Therapy) and stage (Localized, Metastatic Hormone-Sensitive and Castration-Resistant).
Rising cancer cases, earlier detection, precision medicine and a strong pipeline of targeted and immune therapies are driving the prostate Cancer Therapeutics market. Faster approvals and new combinations are improving survival.
Biomarker-led treatment, earlier lines of therapy and expansion into emerging markets offer strong growth for the prostate Cancer Therapeutics market.
High treatment costs, drug resistance, side effects and unequal access to cancer centres hold back the prostate Cancer Therapeutics market, especially in low- and middle-income countries.
The prostate Cancer Therapeutics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
The Emirates Drug Establishment (EDE), set up in 2023, is taking over the regulation of medicines from the Ministry of Health and Prevention.[1] Since January 2025, basic health insurance has been mandatory for all private-sector employees and domestic workers in every emirate.[2]
[1] Emirates Drug Establishment. Checked 14 Nov 2026.
[2] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for prostate Cancer Therapeutics. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in UAE.
What doctors and scientists are doing in Prostate Cancer Therapeutics right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
From our blog
UAE · 2 shared keywords
UAE · 1 shared keyword
UAE · 1 shared keyword
UAE
UAE
UAE
Digital Health · UAE
Medical Devices · UAE
Healthcare Services · UAE
Healthcare Services · UAE
Healthcare Services · UAE
Medical Devices · UAE